about
Using highly detailed administrative data to predict pneumonia mortality.The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.Development and validation of a model that uses enhanced administrative data to predict mortality in patients with sepsis.Maintaining situational awareness in a cardiac intensive care unit.Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia.Comparative Effectiveness of Noninvasive and Invasive Ventilation in Critically Ill Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired PneumoniaThe dangers of extreme body mass index values in patients with Clostridium difficile.Pharmacotherapy of circulatory shock.A State-Level Assessment of Hospital-Based Palliative Care and the Use of Life-Sustaining Therapies in the United States.Risk factor model to predict a missed clinic appointment in an urban, academic, and underserved setting.Using patient admission characteristics alone to predict mortality of critically ill patients: A comparison of 3 prognostic scores.Sepsis and scientific revolutions.Comparison of the Mortality Probability Admission Model III, National Quality Forum, and Acute Physiology and Chronic Health Evaluation IV hospital mortality models: implications for national benchmarking*.Subgroup mortality probability models: are they necessary for specialized intensive care units?Bar-code technology to reduce medication errors.Prospective validation of the intensive care unit admission Mortality Probability Model (MPM0-III).Prolonged acute mechanical ventilation: implications for hospital benchmarking.Comparing observed and predicted mortality among ICUs using different prognostic systems: why do performance assessments differ?Incorporating initial treatments improves the performance of a mortality prediction model based on administrative data.Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.Adaptive leadership: reacting to mission-critical milestones.ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting.Right atrial thrombus leading to altered mental status.Quantifying risk and assessing outcome in cardiac surgery.Timing is everything.Can this patient be safely discharged from the ICU?Severe sepsis outcomes: how are we doing?*.Labetalol: time, experience, and adrenergic blockadeListeria monocytogenes endocarditis on a prosthetic heart valveReversal of hypotension by continuous naloxone infusion in a ventilator-dependent patientWhat if your hospital informatics department could provide a severity adjuster?Daily versus admission mortality estimates: is admission severity yesterday's news?Increased risk and decreased morbidity of coronary artery bypass grafting between 1986 and 1994Assessing contemporary intensive care unit outcome: an updated Mortality Probability Admission Model (MPM0-III)Who's on first?Translational highway: it helps to have a mapA revised method to assess intensive care unit clinical performance and resource utilizationPlacing bets with a full houseDrotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes
P50
Q30749143-76A6FB62-F354-441F-8F2E-9712059ECE38Q33838644-567B0503-93ED-4A36-B2A1-EED2A1CC21CBQ34049856-EE18A639-8741-4F3F-9FC2-E421DF179EA6Q35056842-D555C63A-21D5-4DA2-9415-24E88DE43583Q35432641-9FF07407-0BE8-4C94-8BEE-0224ED37FE53Q35751819-AC3D44CE-29DB-4E0E-86AF-AC7028263BF5Q36991795-D7992E7B-F202-421A-9C24-97468D125933Q38737003-304F43C1-1381-4910-BC7B-F9512D3A3782Q39665896-F25085CD-5B8C-49C6-BB3E-F9AF37F029A8Q40001740-21B1E021-A84F-49A0-B279-2F201DEE824FQ40227586-B7EB80DD-86A1-4E2A-9D6C-6A5FFB6050D8Q41085760-77A7F283-6814-4990-BE76-0D91F3DD3CB8Q42249428-E02F300E-3413-4828-9780-4418B6C38894Q44054384-EE54E7B6-B7B8-439B-94DD-B8FC4B540451Q44103142-64ACDEAC-62A3-4E53-A578-010F3DBED258Q44358483-B4CBF0C3-732D-4AE2-A7E8-2974319CB4FCQ44612004-CD3CF41A-87C3-4CC7-9B01-0E79B92B0814Q45000310-DA00FCB0-801D-4EF4-88B4-0190FBCF6843Q46738819-A0582FDA-BC1E-4B70-BCC4-2DB1385E4518Q47606947-EC486288-20EC-4E94-A363-1100E04E11EEQ47726442-05727B03-74AD-4E0C-ADB9-1E155A14B76CQ47777977-92CDBCE4-5DFE-4E5E-A840-8C6486E5B0B2Q51534690-9938AC02-2502-4E22-9B9A-2A5F67EE0AEAQ51946797-5ACCC8ED-23E7-4FA5-BB75-4A934A233B95Q52241129-EE957C9B-D303-4D1D-88B4-0C9C4CC9F756Q54143986-1E379509-9921-41B4-92FA-0CE980B8EBEAQ56881419-39E550EB-8DA6-4D22-8DBF-B4CE96DE87EBQ64923630-5582890D-9123-4DC5-98F0-7DCE299C8596Q69451433-8EDF9657-545A-42F0-8899-17B668C3D2D6Q71718761-F394CFFF-B6AE-44DE-BA4C-993F02D58FB0Q71726792-37362840-AA72-4583-8E9E-C62928BF1C16Q73139330-34246157-0EDE-4557-B97F-C2E85E6F8E24Q73492560-7886CC1B-DE55-4413-A379-8251009A2C08Q74251823-5FE7C0D0-B709-4845-8FB7-0AC25D63E714Q79667910-DD0FB46D-F406-4FEC-8BD3-1F401134A276Q80186277-37D83D59-C787-42D4-9CD1-44205E0B0DFDQ80187989-FA1D92CF-8F86-44D0-800F-A95B5DECEDA6Q80476038-C97EAD22-E665-4D94-B886-5CC877C6DE7BQ81137932-EE378A7D-3465-4DCE-9A9F-9E261770B7E2Q81464886-750CEE42-7E7C-45B5-997E-4E4D60397329
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9958-0767
@en
name
Thomas L Higgins
@ast
Thomas L Higgins
@en
Thomas L Higgins
@es
Thomas L Higgins
@nl
type
label
Thomas L Higgins
@ast
Thomas L Higgins
@en
Thomas L Higgins
@es
Thomas L Higgins
@nl
prefLabel
Thomas L Higgins
@ast
Thomas L Higgins
@en
Thomas L Higgins
@es
Thomas L Higgins
@nl
P108
P1006
P214
P1006
P106
P1153
57204575044
8123416300
P214
P31
P496
0000-0002-9958-0767
P734
P735
P7859
viaf-280217812